FoxWayne Enterprises Acquisition Corp - Class A

FOXW | $10.25 -0.59% 0

(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (1545.4% volume)
Earnings Calendar:
Market Cap: $ 14,285,200

Sec Filling | Patents | n/a employees

add to watch list Paper trade email alert is off

Viracta Therapeutics Inc

VIRX | $0.831 -5.57% -5.9% 84K

Manufacturing

(0.0% 1d) (-17.0% 1m) (-31.8% 1y) (0.0% 2d) (0.0% 3d) (-6.4% 7d) (-74.1% volume)
Earnings Calendar: 2024-03-13
Market Cap: $ 32,635,393
http://www.sunesis.com/
Sec Filling | Patents | 8 employees

(US) Viracta is a precision oncology company targeting virus-associated malignancies. The Company's proprietary investigational drug, nanatinostat, is currently being evaluated in combination with the antiviral agent valganciclovir as an oral combination therapy in a Phase 2 clinical trial for EBV-positive lymphomas. Viracta is pursuing application of this inducible synthetic lethality approach in other EBV-associated malignancies, such as nasopharyngeal carcinoma, gastric carcinoma, and other virus-related cancers.

cancer antiviral

add to watch list Paper trade email alert is off

Portage Biotech Inc

PRTG | $0.241 -18.91% -23.32% 170K

Mining, Quarrying, and Oil and ...

(0.0% 1d) (-37.9% 1m) (-91.5% 1y) (0.0% 2d) (0.0% 3d) (36.4% 7d) (43.18% volume)
Earnings Calendar: 2023-11-29
Market Cap: $ 4,290,135
https://portagebiotech.com
Sec Filling | Patents | n/a employees

Portage Biotech Inc. is a unique entity in the world of biotechnology, catalyzing R&D to produce more quality clinical programs and maximize potential returns.

add to watch list Paper trade email alert is off

Sports Ventures Acquisition Corp - Class A

AKIC | $10.105 0.0%

(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-86.4% volume)
Earnings Calendar:
Market Cap: $ 239,084,300

Sec Filling | Patents | n/a employees

add to watch list Paper trade email alert is off

Kairos Acquisition Corp - Class A

KAIR | $10.075 0.05% 0.05%

(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (29139.3% volume)
Earnings Calendar:
Market Cap: $ 278,070,000

Sec Filling | Patents | n/a employees

add to watch list Paper trade email alert is off

Arya Sciences Acquisition Corp IV - Class A

ARYD | $11.3 -0.09% 78

(0.0% 1d) (0.3% 1m) (8.5% 1y) (0.0% 2d) (0.0% 3d) (-0.4% 7d) (6725.0% volume)
Earnings Calendar:
Market Cap: $ 42,928,881

Sec Filling | Patents | 3 employees

ARYA Sciences Acquisition Corp IV is a special purpose acquisition company formed for the purpose of entering into a combination with one or more businesses or entities. While the Company may pursue an initial business combination target in any business or industry, it intends to focus on the healthcare industry in the United States and other developed countries. The Company intends to focus on target businesses with valuations of $300 to $500 million or more and that have the potential to be $1 billion or more market capitalization companies.

acquisitions ycombinator

add to watch list Paper trade email alert is off